Target intelligence / Profile preview

LSM2 pseudogene 1 (LSM2P1)

Target
LSM2P1
Molecular classification
Other (Pseudogene)
01

Overview

LSM2 pseudogene 1 (LSM2P1) is a pseudogene related to LSM2, which encodes a member of the LSm family of RNA-binding proteins involved in pre-mRNA splicing and mRNA decay[1][4]. Pseudogenes like LSM2P1 generally do not produce functional protein products and are considered non-functional remnants of genes; however, some pseudogenes can participate in genetic regulation or be expressed as non-coding RNAs, though no such function is validated for LSM2P1[5]. There are no reported roles for LSM2P1 as a therapeutic target, and its entry as a molecular target is incorrect, as it does not encode a functional protein or receptor[1][4][5]. Key clarification: - *LSM2* (not the pseudogene LSM2P1) is the protein-coding homolog, part of RNA metabolism and splicing complexes, and is being actively studied in the context of cancer and RNA processing[1][2][4]. The information and disease linkage in literature generally pertain to LSM2, not to its pseudogene variants. - *LSM2P1* is just a genomic sequence in the human genome, not a functional target, receptor, or enzyme. This entry should not be considered a true molecular target for therapeutic or biomarker development.

Other names
LSM2 homologU6 small nuclear RNA associated pseudogene 1LSM2P1

Beyond the preview

Go deeper on LSM2 pseudogene 1 (LSM2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSM2 pseudogene 1 (LSM2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call